Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_assertion type Assertion NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_head.
- NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_assertion description "[Of the 102 cases of TN-type breast cancer, 24.5% expressed vimentin, 13.7% expressed N-cadherin, and 9.8% expressed smooth muscle actin (SMA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_provenance.
- NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_assertion evidence source_evidence_literature NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_provenance.
- NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_assertion SIO_000772 22439911 NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_provenance.
- NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_assertion wasDerivedFrom befree-20140225 NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_provenance.
- NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_assertion wasGeneratedBy ECO_0000203 NP601421.RAb16g0cq1rtDUhFPMJpkAge4N7x58-kTUpLxBNtzlHgM130_provenance.